scPharmaceuticals Inc expected to post a loss of 36 cents a share - Earnings Preview

Scpharmaceuticals

09/05/2023 03:02

* scPharmaceuticals Inc  SCPH.OQ   SCPH.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 10. 
    * The Burlington Massachusetts-based  company is expected to
report revenue of $1.753 million, according to the mean estimate
from 5 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for scPharmaceuticals
Inc is
for a loss of 36 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
scPharmaceuticals
Inc is $17​, above​ its last closing price of $11.23. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.34       -0.39      -0.30     Beat    22.5
 Sep. 30 2022  -0.36       -0.38      -0.37     Beat    3.3
 Jun. 30 2022  -0.30       -0.30      -0.35     Missed  -15.4​
 Mar. 31 2022  -0.32       -0.31      -0.28     Beat    9.7
 ​​Dec.        -0.32       -0.34      -0.27     Beat    21.4
 31 2021                                                
 Sep. 30 2021  -0.31       -0.31      -0.24     Beat    23.4​
 Jun. 30 2021  -0.30       -0.30      -0.26     Beat    13.3
 Mar. 31 2021  -0.30       -0.30      -0.26     Beat    13.3
 This summary was machine generated May 9 at 02:02 GMT.  All
figures in US dollars  unless otherwise stated